In today’s increasingly competitive global pharmaceutical landscape, choosing a reputable pharmaceutical wholesaler has become a critical strategic decision for pharmaceutical companies, healthcare institutions, and medical

Lung cancer remains the leading cause of cancer death worldwide, with non-small cell lung cancer (NSCLC) accounting for approximately 85% of cases. Thanks to advances

Before the advent of targeted therapy, ALK-positive advanced non-small cell lung cancer (NSCLC) typically progressed rapidly, with a high incidence of brain metastases and limited

Epidermal growth factor receptor EGFR–targeted drugs represent a cornerstone in the treatment of advanced non–small cell lung cancer (NSCLC) harboring EGFR gene mutations. EGFR mutations

In recent years, rare disease treatment has rapidly risen from a niche medical issue to one of the most active core areas of global pharmaceutical

In recent years, immune checkpoint inhibitors have revolutionized the field of anti-tumor treatment, among which PD-1 (programmed death protein 1) monoclonal antibodies have become a

In the field of tenosynovial giant cell tumor (TGCT), a rare but persistent disease that impairs joint function, long-term systemic treatment options are limited. The